An increasing number of people who became ill from the coronavirus have physical, mental and emotional symptoms that linger well after an initial infection

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

The major factors attributing to the growth of this market are increasing demand for paternity testing, rising prevalence of hereditary diseases, and rise in interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits.

Collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home